 |
PDBsum entry 2fxd
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Ligand/metal interactions
|
PDB id
|
|
|
|
2fxd
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Ligand
-
(3s,8s,9s,12s)-3,12-Bis(1,1-Dimethylethyl)-8-Hydroxy-4, 11- Dioxo-9-(Phenylmethyl)-6-[[4-(2-Pyridinyl) phenyl]methyl]- 2,5, 6,10,13-Pentaazatetradecanedioic acid dimethyl ester
[Atazanavir; methyl [(1s,4s,5s,10s)-4-Benzyl-1,10-Di- Tert- Butyl-5-Hydroxy-2,9,12-Trioxo-7-(4-Pyridin-2- Ylbenzyl)-13- Oxa-3,7,8,11-Tetraazatet radec-1- Yl]carbamate]
Formula: C38H52N6O7
|
|
Atoms
| Missing
| Incorrect Chiral Centres
|
| Residue |
Dic. |
Struc. |
Link |
Subs. |
Atoms |
Rings |
Planar |
High |
C |
Other |
|
DR7 102(A) |
51 |
51 |
0 |
0 |
Complete |
Chiral checks - OK |
|
|
|
|
|
Use mouse to move/zoom
|
|
3D Viewers:
|
|
|

|
|

|
|
|
|

LIGPLOT of interactions involving ligand DR7
|
|
|
|

DR7 102(A)
|
|
|
');
}
//
// Otherwise, show static image
//
else
{
//
// Show static image
//
document.getElementById('gldiv').innerHTML
= ' ';
//
// Remove 3Dmol icon and comment
//
if (document.getElementById('3dicon'))
{
document.getElementById('3dicon').innerHTML = '';
}
if (document.getElementById('use_mouse'))
{
document.getElementById('use_mouse').innerHTML = '';
}
}
 |